Augmentation of lenvatinib efficacy by topical treatment of miR-634 ointment in anaplastic thyroid cancer
Anaplastic thyroid cancer (ATC) is one of the most lethal types of human tumors. Lenvatinib can improve the disease control and prognosis in patients with ATC. However, there is an unmet need to develop a therapeutically safer and non-invasive strategy that improves the efficacy of lenvatinib for ad...
Main Authors: | Masahiro Kishikawa, Jun Inoue, Hidetoshi Hamamoto, Katsunori Kobayashi, Takahiro Asakage, Johji Inazawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-07-01
|
Series: | Biochemistry and Biophysics Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405580821001035 |
Similar Items
-
Improving the Efficacy of EGFR Inhibitors by Topical Treatment of Cutaneous Squamous Cell Carcinoma with miR-634 Ointment
by: Jun Inoue, et al.
Published: (2020-12-01) -
Lenvatinib Promotes the Antitumor Effect of Doxorubicin in Anaplastic Thyroid Cancer
by: Su X, et al.
Published: (2020-11-01) -
Survival With Lenvatinib for the Treatment of Progressive Anaplastic Thyroid Cancer: A Single-Center, Retrospective Analysis
by: Soo Young Kim, et al.
Published: (2020-09-01) -
Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration
by: Silvia Martina Ferrari, et al.
Published: (2018-12-01) -
Effective Lenvatinib Treatment Complicated with Secondary Tracheocutaneous Fistula in Patients with Advanced Anaplastic Thyroid Carcinoma
by: Wen-Chi Wu, et al.
Published: (2019-09-01)